The Pipeline Promotion Dilemma: FDA Cites Description Of Investigational Anthrax Vaccine
This article was originally published in The Pink Sheet Daily
Executive Summary
PharmAthene makes changes to fact sheet on SparVax after CBER's advertising branch finds that the claims "strongly suggest" the vaccine will be safe and effective.